By using bioinformatics computer programs, all foot-and-mouth disease virus (FMDV) genome sequences in public-domain databases were analyzed. Based on the results of homology analysis, 2 specific small interfering RNA (siRNA) targeting homogenous 3D and 2B1 regions of 7 serotypes of FMDV were prepared and 2 siRNA-expression vectors, pSi-FMD2 and pSi-FMD3, were constructed. The siRNA-expressing vectors were used to test the ability of siRNAs to inhibit virus replication in baby hamster kidney (BHK-21) cells and suckling mice, a commonly used small animal model. The results demonstrated that transfection of BHK-21 cells with siRNA-expressing plasmids significantly weakened the cytopathic effect (CPE). Moreover, BHK-21 cells transiently transfected with short hairpin RNA (shRNA)-expressing plasmids were specifically resistant to the infection of the FMDV serotypes A, O, and Asia I and this the antiviral effects persisted for almost 48 hours. We measured the viral titers, the 50% tissue culture infective dose (TCID50) in cells transfected with anti-FMDV siRNAs was found to be lower than that of the control cells. Furthermore, subcutaneous injection of siRNA-expressing plasmids in the neck of the suckling mice made them less susceptible to infection with O, and Asia I serotypes of FMDV.
3 November 2025 in Frontiers in Veterinary Science
To address the need for rapid detection of Salmonella pullorum ( S. pullorum) and Salmonella typhimurium ( S. typhimurium) in the poultry industry, we developed a dual-target point-of-care system integrating recombinase-aided amplification (RAA) with lateral flow dipsticks (LFD) for visual pathogen identification (RAA-LFD). Using primers and probes specifically targeting the ipaj gene of S. pullorum and the STM4497 gene of S. typhimurium, the optimized assay achieved detection at 37 °C within 20 min. The dual RAA-LFD assay showed exceptional specificity with no cross-reactivity toward non-target pathogens. Detection sensitivities reached 5.91 × 10 1 CFU/mL ( S. typhimurium) and 2.37 × 10 2 CFU/mL ( S. pullorum) in pure cultures. In contrast, genomic DNA detection achieved identical limits of 5.70 × 10 1 fg/μL ( S. typhimurium) and 4.53 × 10 1 fg/μL ( S. pullorum). In artificially contaminated samples, the detection limits reached 3.92 × 10 2 CFU/mL for S. pullorum and 6.26 × 10 1 CFU/mL for S. typhimurium. Clinical validation demonstrated 96.88–100% coincidence with biochemical identification and multiplex PCR results. This study confirms the precision and high sensitivity of the dual RAA-LFD assay as a detection methodology. Furthermore, by eliminating reliance on complex traditional techniques, this technology provides an efficient grassroots-level field screening tool with significant potential for preventing avian salmonellosis and enhancing food safety monitoring.
Background: Clostridium perfringens type A is the primary pathogenic bacterium responsible for bovine necrotic enteritis, causing significant economic losses in large-scale livestock farming. Our previous reverse vaccinology screen identified the nontoxin antigen protein of this bacterium as highly immunogenic. However, its immune protection efficacy and practical effectiveness in vaccines remain unclear. Methods: Antigenic epitope analysis, prokaryotic expression, and purification of the C. perfringens Plc, ESBP, and YnjE proteins were performed. Mice were immunized with these proteins to detect serum antibody titers, cytokine levels, and changes in the mouse survival rate and weight. The immunoprotective effects of ESBP and YnjE proteins as well as three commercial vaccines were compared by detecting serum antibody titers against the toxin protein Plc and the non-toxin proteins ESBP and YnjE proteins after three immunizations with the vaccines. Results: Three proteins with high immunogenicity scores (the classic toxin protein Plc and non-toxin proteins ESBP and YnjE) were successfully expressed and purified. ELISA of mouse sera showed significantly elevated levels of IL-2, IL-4, IL-10, and IFN-γ, indicating the induction of a mixed Th1/Th2 immune response. Indirect ELISA confirmed that all three proteins elicited high IgG titers, with the non-toxin ESBP and YnjE inducing higher titers. Their protective efficacy—based on survival rate and body weight recovery—was superior to Vac3, comparable to Vac2, and lower than Vac1. Notably, sera from mice immunized with the three commercial vaccines exhibited low antibody titers against ESBP and YnjE, suggesting that the immunological potential of these two key non-toxin protective antigens is not fully exploited in current vaccines. Conclusion: ESBP and YnjE exhibited favorable immunogenicity and immune protection in a mouse model. These findings, derived from the mouse model, highlight the great potential of ESBP and YnjE as key candidate antigens for the development of novel vaccines, and provide important experimental evidence for the antigen design and optimization of C.perfringens vaccines. These conclusions need to be further validated by in-farm animal trials.
25 February 2026 in International Journal of Biological Macromolecules